Company News & Updates

Transneural Therapeutics Appoints CNS Drug Development Expert, Mark A. Demitrack, MD, as Chief Research and Development Officer

Accomplished physician-scientist brings more than 30 years of industry leadership experience and CNS drug development expertise.

Transneural Therapeutics Emerges from Stealth to Transform the Treatment of Neuropsychiatric Diseases with Novel Neuroplastogens

Transneural has assembled a team of scientific and strategic experts in neuropsychiatry to take on the challenge of transforming outcomes for patients and families

Contact Us

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.